| |
| |
|
| Insider
Information: |
Berstein David L |
| Relationship: |
SVP, Chief IP Counsel |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
262,115 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
262,115 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ariad Pharmaceuticals Inc |
ARIA |
SVP, Chief IP Counsel |
2016-03-21 |
262,115 |
2003-09-16 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Chief IP Counsel |
• • – |
2016-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
19,250 |
269,365 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Chief IP Counsel |
• • – |
2016-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
29,333 |
264,782 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Chief IP Counsel |
• – – |
2016-03-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,750 |
264,490 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Chief IP Counsel |
• – – |
2016-03-21 |
4 |
AS |
$6.47 |
$15,356 |
D/D |
(2,375) |
262,115 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Chief IP Counsel |
• • – |
2016-03-03 |
4 |
AS |
$6.12 |
$58,887 |
D/D |
(9,625) |
259,740 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Senior VP, Chief IP Officer |
• – – |
2011-06-07 |
4 |
OE |
$5.65 |
$339,000 |
D/D |
60,000 |
258,801 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Senior VP, Chief IP Officer |
• – – |
2012-05-02 |
4 |
OE |
$4.19 |
$47,661 |
D/D |
11,375 |
257,231 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Senior VP, Chief IP Officer |
• – – |
2012-03-26 |
4 |
OE |
$4.19 |
$47,661 |
D/D |
11,375 |
253,631 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Senior VP, Chief IP Officer |
• – – |
2012-03-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
26,333 |
252,789 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Chief IP Counsel |
• • – |
2015-09-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,000 |
250,449 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Chief IP Counsel |
• • – |
2016-02-01 |
4 |
AS |
$4.81 |
$70,515 |
D/D |
(14,667) |
250,115 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Senior VP, Chief IP Officer |
• – – |
2012-03-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
47,000 |
245,256 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Senior VP, Chief IP Officer |
• – – |
2012-03-23 |
4 |
AS |
$15.41 |
$162,274 |
D/D |
(10,533) |
242,256 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Senior VP, Chief IP Officer |
• – – |
2012-03-26 |
4 |
AS |
$16.00 |
$182,000 |
D/D |
(11,375) |
242,256 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Chief IP Counsel |
• • – |
2015-09-24 |
4/A |
OE |
$0.00 |
$0 |
D/D |
10,000 |
240,449 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Chief IP Counsel |
• • – |
2015-09-28 |
4 |
AS |
$6.46 |
$32,316 |
D/D |
(5,000) |
240,449 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, GC and Chief IP Officer |
• • – |
2014-07-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,000 |
238,642 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Senior VP, Chief IP Officer |
• – – |
2012-05-02 |
4 |
AS |
$17.00 |
$329,375 |
D/D |
(19,375) |
237,856 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Senior VP, Chief IP Officer |
• – – |
2012-02-21 |
4 |
OE |
$3.90 |
$88,920 |
D/D |
22,800 |
237,456 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, GC and Chief IP Officer |
• • – |
2014-09-09 |
4 |
D |
$5.75 |
$40,929 |
D/D |
(7,118) |
236,741 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Chief IP Counsel |
• • – |
2015-02-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
29,334 |
236,741 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, GC and Chief IP Officer |
• • – |
2014-07-15 |
4 |
D |
$5.57 |
$14,527 |
D/D |
(2,608) |
236,034 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Chief IP Counsel |
• • – |
2015-09-28 |
4/A |
AS |
$6.46 |
$32,316 |
D/D |
(5,000) |
235,449 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, Chief IP Counsel |
• • – |
2015-07-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,000 |
234,449 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
SVP, GC and Chief IP Officer |
• • – |
2014-04-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,000 |
233,042 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
